Too big, too small: selecting hematoma sizes for inclusion in intracerebral hemorrhage-deferoxamine trials

Transl Stroke Res. 2023 Jun;14(3):281-282. doi: 10.1007/s12975-022-01013-8. Epub 2022 Mar 28.

Authors

Fenghui Ye¹, Yingfeng Wan¹, Sravanthi Koduri¹, Katherine G Holste¹, Richard F Keep¹, Ya Hua¹, Guohua Xi²

Affiliations

¹ Department of Neurosurgery, University of Michigan, R5018 Biomedical Science Research Building, 109 Zina Pitcher Place, Ann Arbor, MI, 48109-2200, USA.
² Department of Neurosurgery, University of Michigan, R5018 Biomedical Science Research Building, 109 Zina Pitcher Place, Ann Arbor, MI, 48109-2200, USA. guohuaxi@umich.edu.

PMID: 35344186
PMCID: PMC9792076 (available on 2024-06-01)
DOI: 10.1007/s12975-022-01013-8

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Cerebral Hemorrhage* / drug therapy
Deferoxamine*
Hematoma / chemically induced
Hematoma / drug therapy
Humans

Substances

Deferoxamine

Grants and funding